Other studies have confirmed that the inhibition of COX-2 expression increases the sensitivity of cancer cells to radiation, and COX-2 signaling is a potential therapeutic target for consolidating cancer treatment [19,20,21]. This evidence concerns the gene PTGS2 and cancer.